Go Back
Twist Bioscience Corp reports $59.2 million Q2 profit
By USInMinutes - May 05, 2023, 02:37 PM ET
Last Updated - Jul 18, 2023, 03:37 PM EDT
The company generated $60.20 million in quarterly revenue
Twist Bioscience Corp [TWST] has reported fiscal Q2 profit of $59.20 million.
On a per-share basis, the DE based company said its diluted earnings are $1.04.
The Biological Products, Except Diagnostic Substances firm posted revenue of $60.20 million in this period.
Also Read:
- Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
- Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
- Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies
- Twist Bioscience to Report Fiscal 2023 Second Quarter Financial Results on Friday, May 5, 2023
- Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News
